WERTINE 16 contains Betahistine 16 mg, formulated for the management of vertigo and associated vestibular symptoms, including those seen in Ménière’s disease. A focused PCD Pharma Vertigo portfolio product.
Vertigo and Ménière’s disease-related symptoms.
Symptom improvement may require continued treatment.
Take regularly as prescribed, preferably with food if gastric irritation occurs. Inform the physician about peptic ulcer disease, asthma or other relevant conditions.
Headache, nausea, indigestion, abdominal discomfort and mild skin reactions may occur.
WERTINE 16: Betahistine acts primarily on histamine receptors and is used to improve inner-ear microcirculatory function, supporting reduction of vertigo-related symptoms in appropriate patients.
